EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mast cells in tumors: dual roles and therapeutic potential

Dekun Song, Guorong Yan, Guolong Zhang

Cancer Immunology, Immunotherapy · 19.07.2026

DOI: 10.1007/s00262-026-04477-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 19.07.2026. Verfasst von Dekun Song und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Phototherapy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mast cells (MCs) are tissue-resident immune cells that accumulate in the tumor microenvironment (TME) and display marked functional plasticity. Rather than acting through fixed pro-tumor or anti-tumor phenotypes, tumor-associated MCs acquire functional programs shaped by tumor type, spatial localization, disease stage, and local microenvironmental cues. In this review, we organize these dual roles around cellular crosstalk, mediator release, angiogenic and lymphangiogenic regulation, and extracellular matrix remodeling. Through these interconnected mechanisms, MCs may either promote tumor progression by reinforcing immunosuppression, limiting effector T cell activity, and supporting vascular, lymphatic, and stromal remodeling, or contribute to tumor suppression by promoting tumor cell apoptosis, antigen presentation, cytotoxic immune-cell recruitment, and anti-tumor mediator release. We also examine MC responses to various cancer treatments, including physical treatment modalities, chemotherapy, immunotherapy, targeted therapy, and CAR-based cell therapies, and discuss how these responses may influence therapeutic efficacy and treatment-related toxicity. Furthermore, we highlight emerging MC-targeted strategies that either suppress their chronic pro-tumor secretion or intentionally induce acute anti-tumor degranulation. By deciphering the dual nature of MCs in cancer, this review underscores the potential for reprogramming MCs to improve tumor treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

Anti-tumorHeterogeneityMast cellsPro-tumorTumor microenvironment

Autor:innen und Institutionen

  • Department of Phototherapy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
  • Skin Cancer Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China.
  • Institute of Photomedicine, School of Medicine, Tongji University, Shanghai, 200443, China.
  • Department of Phototherapy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China. guorongyan@tongji.edu.cn.
  • Skin Cancer Center, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China. guorongyan@tongji.edu.cn.
  • Institute of Photomedicine, School of Medicine, Tongji University, Shanghai, 200443, China. guorongyan@tongji.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Song, D., Yan, G., & Zhang, G. (2026). Mast cells in tumors: dual roles and therapeutic potential. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04477-x

Vancouver

Song D, Yan G, Zhang G. Mast cells in tumors: dual roles and therapeutic potential. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04477-x

BibTeX
@article{Song2026,
  author = {Song, Dekun and Yan, Guorong and Zhang, Guolong},
  title = {Mast cells in tumors: dual roles and therapeutic potential},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04477-x}
}
Kostenlos starten →